Showing results (221-230 of 265) with videos related to

Sort By:
Pageof 27
Oncogene|August 24, 2010
TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cellsG M Marshall, J L Bell, J Koach, et al.
Molecular Oncology|March 22, 2016
Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesisDaniel R Carter, Selina K Sutton, Marina Pajic, et al.
The Journal of Biological Chemistry|April 26, 2006
The estrogen-responsive B box protein is a novel regulator of the retinoid signalBelamy B Cheung, Jessica Bell, Anna Raif, et al.
Vaccine|March 9, 2010
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trialF M Russell, J R Carapetis, A Balloch, et al.
Scientific Reports|September 11, 2019
The association of gut microbiota characteristics in Malawian infants with growth and inflammationArox W Kamng'ona, Rebecca Young, Charles D Arnold, et al.
Nature Communications|March 26, 2021
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stabilityZsuzsanna Nagy, Janith A Seneviratne, Maxwell Kanikevich, et al.
Global Spine Journal|July 18, 2020
Automated Measurement of Lumbar Lordosis on Radiographs Using Machine Learning and Computer VisionBrian H Cho, Deepak Kaji, Zoe B Cheung, et al.
Cancers|March 29, 2023
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein InterfaceHassina Massudi, Jie-Si Luo, Jessica K Holien, et al.
American Journal of Respiratory and Critical Care Medicine|March 6, 2020
Airway Oscillometry Detects Spirometric-Silent Episodes of Acute Cellular RejectionElizabeth Cho, Joyce K Y Wu, Daniella Cunha Birriel, et al.
Molecular Oncology|May 13, 2015
Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastomaBelamy B Cheung, Owen Tan, Jessica Koach, et al.
Pageof 27